Table 4. Recommended dosage and administration for the nonbenzodiazepine sedative hypnotics1–7.
Recommended dose | Maximum dose | Dose adjustments in special populations | ||
Suvorexant | 10 mg once daily within 30 minutes of going to bed | 20 mg once daily | With moderate CYP3A inhibitors, the recommended dose is 5 mg and the maximum dose is 10 mg. Not recommended in patients requiring treatment with a strong CYP3A inhibitor | |
Doxepin | 3 to 6 mg within 30 minutes of going to bed | 6 mg/day | Recommended starting dose is 3 mg in the elderly and those with hepatic impairment | |
Eszopiclone | 1 mg immediately before bedtime | 3 mg once daily | Not to exceed 2 mg in the elderly or debilitated, in patients with severe hepatic impairment, or with coadministration of potent CYP3A4 inhibitors | |
Ramelteon | 8 mg within 30 minutes of going to bed | 8 mg per day | None | |
Zaleplon | 5 to 10 mg immediately before bedtime | 20 mg once daily | In the elderly or debilitated, the recommended dose is 5 mg and maximum dose is 10 mg. In mild to moderate hepatic impairment, the recommended dose is 5 mg. With cimetidine, the initial dose is 5 mg. |
|
Zolpidem extended release | 6.25 mg for women and 6.25 or 12.5 mg for men immediately before bedtime | 12.5 mg once daily | Recommended dose is 6.25 mg for the elderly and those with hepatic impairment. | |
Zolpidem tablets | 5 mg for women and 5 to 10 mg for men immediately before bedtime | 10 mg once daily | Recommended dose is 5 mg in the elderly and debilitated, and those with hepatic impairment. |